These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. DeepHLApan: A Deep Learning Approach for Neoantigen Prediction Considering Both HLA-Peptide Binding and Immunogenicity. Wu J; Wang W; Zhang J; Zhou B; Zhao W; Su Z; Gu X; Wu J; Zhou Z; Chen S Front Immunol; 2019; 10():2559. PubMed ID: 31736974 [TBL] [Abstract][Full Text] [Related]
25. Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors. Chen F; Zou Z; Du J; Su S; Shao J; Meng F; Yang J; Xu Q; Ding N; Yang Y; Liu Q; Wang Q; Sun Z; Zhou S; Du S; Wei J; Liu B J Clin Invest; 2019 May; 129(5):2056-2070. PubMed ID: 30835255 [TBL] [Abstract][Full Text] [Related]
26. Peptide Presentation to T Cells: Solving the Immunogenic Puzzle: Systems Immunology Profiling of Antigen Presentation for Prediction of CD8 Croft NP Bioessays; 2020 Mar; 42(3):e1900200. PubMed ID: 31958157 [TBL] [Abstract][Full Text] [Related]
27. DLpTCR: an ensemble deep learning framework for predicting immunogenic peptide recognized by T cell receptor. Xu Z; Luo M; Lin W; Xue G; Wang P; Jin X; Xu C; Zhou W; Cai Y; Yang W; Nie H; Jiang Q Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34415016 [TBL] [Abstract][Full Text] [Related]
28. Design of Peptide-Based Nanovaccines Targeting Leading Antigens From Gynecological Cancers to Induce HLA-A2.1 Restricted CD8 Xiang SD; Wilson KL; Goubier A; Heyerick A; Plebanski M Front Immunol; 2018; 9():2968. PubMed ID: 30631324 [TBL] [Abstract][Full Text] [Related]
29. DeepImmuno: deep learning-empowered prediction and generation of immunogenic peptides for T-cell immunity. Li G; Iyer B; Prasath VBS; Ni Y; Salomonis N Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34009266 [TBL] [Abstract][Full Text] [Related]
30. Improved predictions of antigen presentation and TCR recognition with MixMHCpred2.2 and PRIME2.0 reveal potent SARS-CoV-2 CD8 Gfeller D; Schmidt J; Croce G; Guillaume P; Bobisse S; Genolet R; Queiroz L; Cesbron J; Racle J; Harari A Cell Syst; 2023 Jan; 14(1):72-83.e5. PubMed ID: 36603583 [TBL] [Abstract][Full Text] [Related]
31. What do cancer-specific CD8+ T cells see? The contribution of immunopeptidomics. Nicholas B; Skipp P Essays Biochem; 2023 Sep; 67(6):957-965. PubMed ID: 37503576 [TBL] [Abstract][Full Text] [Related]
32. Structural in silico analysis of cross-genotype-reactivity among naturally occurring HCV NS3-1073-variants in the context of HLA-A*02:01 allele. Antunes DA; Rigo MM; Silva JP; Cibulski SP; Sinigaglia M; Chies JA; Vieira GF Mol Immunol; 2011 Jul; 48(12-13):1461-7. PubMed ID: 21513985 [TBL] [Abstract][Full Text] [Related]
33. 'Hotspots' of Antigen Presentation Revealed by Human Leukocyte Antigen Ligandomics for Neoantigen Prioritization. Müller M; Gfeller D; Coukos G; Bassani-Sternberg M Front Immunol; 2017; 8():1367. PubMed ID: 29104575 [TBL] [Abstract][Full Text] [Related]
34. Identification of promiscuous KIF20A long peptides bearing both CD4+ and CD8+ T-cell epitopes: KIF20A-specific CD4+ T-cell immunity in patients with malignant tumor. Tomita Y; Yuno A; Tsukamoto H; Senju S; Kuroda Y; Hirayama M; Irie A; Kawahara K; Yatsuda J; Hamada A; Jono H; Yoshida K; Tsunoda T; Kohrogi H; Yoshitake Y; Nakamura Y; Shinohara M; Nishimura Y Clin Cancer Res; 2013 Aug; 19(16):4508-20. PubMed ID: 23714729 [TBL] [Abstract][Full Text] [Related]
35. Peptide epitopes from the Wilms' tumor 1 oncoprotein stimulate CD4+ and CD8+ T cells that recognize and kill human malignant mesothelioma tumor cells. May RJ; Dao T; Pinilla-Ibarz J; Korontsvit T; Zakhaleva V; Zhang RH; Maslak P; Scheinberg DA Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4547-55. PubMed ID: 17671141 [TBL] [Abstract][Full Text] [Related]
36. An immunogenic personal neoantigen vaccine for patients with melanoma. Ott PA; Hu Z; Keskin DB; Shukla SA; Sun J; Bozym DJ; Zhang W; Luoma A; Giobbie-Hurder A; Peter L; Chen C; Olive O; Carter TA; Li S; Lieb DJ; Eisenhaure T; Gjini E; Stevens J; Lane WJ; Javeri I; Nellaiappan K; Salazar AM; Daley H; Seaman M; Buchbinder EI; Yoon CH; Harden M; Lennon N; Gabriel S; Rodig SJ; Barouch DH; Aster JC; Getz G; Wucherpfennig K; Neuberg D; Ritz J; Lander ES; Fritsch EF; Hacohen N; Wu CJ Nature; 2017 Jul; 547(7662):217-221. PubMed ID: 28678778 [TBL] [Abstract][Full Text] [Related]
37. The identification of effective tumor-suppressing neoantigens using a tumor-reactive TIL TCR-pMHC ternary complex. Kim SH; Lee BR; Kim SM; Kim S; Kim MS; Kim J; Lee I; Kim HS; Nam GH; Kim IS; Song K; Choi Y; Lee DS; Park WY Exp Mol Med; 2024 Jun; ():. PubMed ID: 38866910 [TBL] [Abstract][Full Text] [Related]
38. Amino Acid Substitutions within HLA-B*27-Restricted T Cell Epitopes Prevent Recognition by Hepatitis Delta Virus-Specific CD8 Karimzadeh H; Kiraithe MM; Kosinska AD; Glaser M; Fiedler M; Oberhardt V; Salimi Alizei E; Hofmann M; Mok JY; Nguyen M; van Esch WJE; Budeus B; Grabowski J; Homs M; Olivero A; Keyvani H; Rodríguez-Frías F; Tabernero D; Buti M; Heinold A; Alavian SM; Bauer T; Schulze Zur Wiesch J; Raziorrouh B; Hoffmann D; Smedile A; Rizzetto M; Wedemeyer H; Timm J; Antes I; Neumann-Haefelin C; Protzer U; Roggendorf M J Virol; 2018 Jul; 92(13):. PubMed ID: 29669837 [TBL] [Abstract][Full Text] [Related]
39. Discovery of immunodominant T-cell epitopes reveals penton protein as a second immunodominant target in human adenovirus infection. Tischer S; Geyeregger R; Kwoczek J; Heim A; Figueiredo C; Blasczyk R; Maecker-Kolhoff B; Eiz-Vesper B J Transl Med; 2016 Oct; 14(1):286. PubMed ID: 27717382 [TBL] [Abstract][Full Text] [Related]
40. HLA class I loss in metachronous metastases prevents continuous T cell recognition of mutated neoantigens in a human melanoma model. Schrörs B; Lübcke S; Lennerz V; Fatho M; Bicker A; Wölfel C; Derigs P; Hankeln T; Schadendorf D; Paschen A; Wölfel T Oncotarget; 2017 Apr; 8(17):28312-28327. PubMed ID: 28423700 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]